In a recent market downturn, several healthcare stocks, including Azenta, Myriad Genetics, Moderna, Repligen, and PacBio, experienced notable declines. This decline was part of a broader sell-off in growth equities that require significant capital investment. The sell-off was driven by rising bond yields, which have reduced market appetite for riskier investments. According to financial analysts … Continue reading "Rising Bond Yields Trigger Dec…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.